ArticleCureus2025
A Study of Clinical Profile and Factors Affecting Mortality in Patients With Acute-on-Chronic Liver Failure in a Tertiary Care Hospital in Nepal.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and aim Acute-on-chronic liver failure (ACLF) is a dynamic condition with very high short-term mortality. Although several mortality predictors have been studied, no single factor can reliably predict its course and outcome. This study aimed to evaluate various biochemical parameters and severity scores at presentation to assess their ability to predict mortality in ACLF patients. Methods An observational cross-sectional study was conducted from March 2024 to February 2025 at a tertiary care center in Nepal. A total of 51 patients were enrolled over one year. ACLF was diagnosed based on the Asia-Pacific Association for the Study of the Liver (APASL) criteria and/or the European Association for the Study of the Liver-Chronic Liver Failure Consortium (EASL-CLIF) criteria. Clinical features, biochemical parameters, and severity scores at admission were analyzed. Results The overall mortality rate was high (56.9%), consistent with previous studies. About 28% of patients who met the APASL definition of ACLF did not fulfill the EASL-CLIF criteria. On univariate analysis, factors such as oliguria, hepatic encephalopathy (HE) grade, ACLF grade, total serum protein, urea, ascitic fluid total leukocyte count, serum lactate, and APASL-ACLF Research Consortium (AARC) score were associated with mortality. However, multivariate analysis did not identify a single independent predictor of mortality. Different scoring systems were useful in predicting mortality at admission. Among them, the CLIF-C ACLF score had the highest predictive accuracy (area under the curve (AUC): 0.990), followed by the AARC score (AUC: 0.79), Sequential Organ Failure Assessment (SOFA) score, and Model for End-Stage Liver Disease (MELD) score. However, the Child-Turcotte-Pugh (CTP) score at admission was not effective in predicting mortality. Conclusion ACLF represents an acute flare of inflammation on a background of chronic liver disease. Using multiple mortality predictors at the time of admission can help guide treatment decisions and provide better prognostication of patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.